Table 1. - Demographic, clinical, and functional characteristics of the participants.a.

Characteristic	Groups			p
	Asthma	COPD	Control
	(n = 21)	(n = 19)	(n = 10)
Age, yearsb	47.3 (22-68)	62.8 (52-77)	38.4 (21-58)	< 0.001*.*** and 0.2**
Female genderc	12 (57.0)	5 (26.3)	7 (70.0)	0.03
Pre-BD FEV1,% of predicted	55.3 ± 11.9	50.2 ± 18.2	102.2 ± 7.8	0.1* and < 0.001**.***
Post-BD FEV1,% of predicted	64.9 ± 11.7	52.7 ± 18.2	104.5 ± 8.7	0.02* and < 0.001**.***
Pre-BD FEV1/FVC, %	58.3 ± 9.5	52.5± 13.8	80.4 ± 5.0	0.4* and < 0.001**.***
Post-BD FEV1/FVC,%	61.3 ± 9.2	53.2 ± 14.4	82.4 ± 4.6	0.06* and < 0.001**.***
Pre-BD ΔFEV1, L	0.29 ± 0.29	0.07 ± 0.09	0.08 ± 0.08	0.003*, 0.02**, and 1.0***
Post-BD ΔFEV1, %	19.1 ± 17.6	6.1 ± 7.4	2.5 ± 2.4	0.005*, 0.002**, and 1.0***

^Pré-BD: antes do uso de broncodilatador

^pós-BD: depois do uso de broncodilatador

^aValores expressos em média ± dp, exceto onde indicado.

^bValor expresso em média (mínimo-máximo).

^cValor expresso em n (%)

^*Grupo asma vs. grupo DPOC

^**Grupo asma vs. controle

^***Grupo DPOC vs. controle